rs201242614
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000235.4(LIPA):c.966+3A>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000143 in 1,601,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000235.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIPA | NM_000235.4 | c.966+3A>T | splice_region_variant, intron_variant | ENST00000336233.10 | NP_000226.2 | |||
LIPA | NM_001127605.3 | c.966+3A>T | splice_region_variant, intron_variant | NP_001121077.1 | ||||
LIPA | NM_001288979.2 | c.618+3A>T | splice_region_variant, intron_variant | NP_001275908.1 | ||||
LIPA | XM_024448023.2 | c.966+3A>T | splice_region_variant, intron_variant | XP_024303791.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIPA | ENST00000336233.10 | c.966+3A>T | splice_region_variant, intron_variant | 1 | NM_000235.4 | ENSP00000337354.5 | ||||
LIPA | ENST00000371837.5 | c.798+3A>T | splice_region_variant, intron_variant | 2 | ENSP00000360903.1 | |||||
LIPA | ENST00000456827.5 | c.618+3A>T | splice_region_variant, intron_variant | 3 | ENSP00000413019.2 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152214Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251392Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135898
GnomAD4 exome AF: 0.000140 AC: 203AN: 1449202Hom.: 0 Cov.: 28 AF XY: 0.000139 AC XY: 100AN XY: 721908
GnomAD4 genome AF: 0.000171 AC: 26AN: 152332Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 14AN XY: 74494
ClinVar
Submissions by phenotype
Lysosomal acid lipase deficiency Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 26, 2021 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 31, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Mar 20, 2017 | - - |
LIPA-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 13, 2024 | The LIPA c.966+3A>T variant is predicted to interfere with splicing. This variant has been reported in an individual with hypercholesterolaemia (Sjouke et al 2016. PubMed ID: 27423329). This variant has been reported in 0.028% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 04, 2023 | Variant summary: LIPA c.966+3A>T alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00015 in 251392 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in LIPA causing Lysosomal Acid Lipase Deficiency (0.00015 vs 0.0027), allowing no conclusion about variant significance. c.966+3A>T has been reported in the literature in an individual affected with familial hypercholesterolemia (example:Sjouke_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Lysosomal Acid Lipase Deficiency. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Wolman disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | This sequence change falls in intron 9 of the LIPA gene. It does not directly change the encoded amino acid sequence of the LIPA protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs201242614, gnomAD 0.03%). This variant has been observed in individual(s) with hypercholesterolemia (PMID: 27423329). ClinVar contains an entry for this variant (Variation ID: 499076). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 09, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at